Page last updated: 2024-12-05

thonzylamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

thonzylamine: major descriptor (72-84); file-maintained to PYRIMIDINES [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5457
CHEMBL ID1623738
CHEBI ID104017
SCHEMBL ID121996
MeSH IDM0262803

Synonyms (79)

Synonym
tonzilamina [dcit]
toncilaminio [inn-spanish]
pyrimidine, 2-((2-(dimethylamino)ethyl)(p-methoxybenzyl)amino)-
brn 0284655
thonzylamine
einecs 202-103-8
neohetramine
thonzylaminum [inn-latin]
ethylenediamine, n-(p-methoxybenzyl)-n',n'-dimethyl-n-2-pyrimidinyl-
thonzylamine [inn:ban]
nci-c60708
tonzilamine
n,n-dimethyl-n'-(p-methoxybenzyl)-n'-(2-pyrimidyl)ethylenediamine
2-((2-(dimethylamino)ethyl)(p-methoxybenzyl)amino)pyrimidine
BRD-K88405679-003-01-5
1,2-ethanediamine, n-[(4-methoxyphenyl)methyl]-n',n'-dimethyl-n-2-pyrimidinyl-
pyrimidine, 2-[[2-(dimethylamino)ethyl](p-methoxybenzyl)amino]-
KBIO1_000378
DIVK1C_000378
SPECTRUM_000411
BSPBIO_003315
IDI1_000378
KBIO2_006027
KBIO2_000891
KBIO2_003459
KBIOGR_001608
KBIOSS_000891
KBIO3_002817
SPECTRUM4_001204
SPECTRUM3_001788
NINDS_000378
NCGC00178145-01
tonamil (tn)
thonzylamine (inn)
91-85-0
D08587
n'-[(4-methoxyphenyl)methyl]-n,n-dimethyl-n'-pyrimidin-2-ylethane-1,2-diamine
n'-[(4-methoxyphenyl)methyl]-n,n-dimethyl-n'-(2-pyrimidinyl)ethane-1,2-diamine
CHEBI:104017
AKOS016010333
CHEMBL1623738
tonamil
r79646h5z8 ,
1,2-ethanediamine, n-((4-methoxyphenyl)methyl)-n',n'-dimethyl-n-2-pyrimidinyl-
toncilaminio
tonzilamina
unii-r79646h5z8
4-25-00-02087 (beilstein handbook reference)
thonzylaminum
thonzylamine [inn]
thonzylamine [who-dd]
S6469
SCHEMBL121996
anohist (salt/mix)
anahist (salt/mix)
n-(4-methoxybenzyl)-n',n'-dimethyl-n-pyrimidin-2-ylethane-1,2-diamine
2-[p-methoxybenzyl-(2-dimethylaminoethyl)amino]pyrimidine
resistab (salt/mix)
novohetramin (salt/mix)
GULNIHOSWFYMRN-UHFFFAOYSA-N
DTXSID8043864
n1-(4-methoxybenzyl)-n2,n2-dimethyl-n1-(pyrimidin-2-yl)ethane-1,2-diamine
AB00053649_02
CS-0013078
HY-B1317
SBI-0051778.P002
DB11235
BCP25799
tonzilamine;neohetramine
Q617226
n-(4-methoxybenzyl)-n-(2-(dimethylamino)ethyl)pyrimidin-2-amine
AMY10719
BRD-K88405679-003-02-3
SB59763
EX-A5550
n-[2-(dimethylamino)ethyl]-n-[(4-methoxyphenyl)methyl]pyrimidin-2-amine
EN300-18563897
F87601
n-[(4-methoxyphenyl)methyl]-n',n'-dimethyl-n-pyrimidin-2-ylethane-1,2-diamine hydrochloride
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
methoxybenzenesAny aromatic ether that consists of a benzene skeleton substituted with one or more methoxy groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Thonzylamine H1-Antihistamine Action87

Bioassays (2)

Assay IDTitleYearJournalArticle
AID624608Specific activity of expressed human recombinant UGT1A42000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-199018 (81.82)18.7374
1990's0 (0.00)18.2507
2000's2 (9.09)29.6817
2010's1 (4.55)24.3611
2020's1 (4.55)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.43 (24.57)
Research Supply Index3.26 (2.92)
Research Growth Index4.53 (4.65)
Search Engine Demand Index36.32 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other24 (96.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]